PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor

被引：0
|
作者：
Jiang, J. [1 ]
Shi, L. [1 ]
Chen, L. [1 ]
Zhu, Y. [1 ]
Wu, C. [1 ]
Lu, B. [2 ]
机构：
[1] Soochow Univ, Dept Tumor Biol Treatment, Affiliated Hosp 3, Changzhou, Peoples R China
[2] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2016年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
183
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [21] Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis
    Wang, Xiaofei
    Liu, Guo
    Chen, Shu
    Bi, Huaqiang
    Xia, Feng
    Feng, Kai
    Ma, Kuansheng
    Ni, Bing
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2021, 38 (01) : 1519 - 1528
  • [22] Anti-PD-L1 blockade facilitates antitumor effects of radiofrequency ablation by improving tumor immune microenvironment in hepatocellular carcinoma
    Liang, Jiahua
    Ma, Mingjian
    Feng, Wei
    Xu, Qiongcong
    Chen, Dong
    Lai, Jiaming
    Chen, Jiancong
    APOPTOSIS, 2025, 30 (1-2) : 55 - 68
  • [23] Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
    John, Liza B.
    Kershaw, Michael H.
    Darcy, Phillip K.
    ONCOIMMUNOLOGY, 2013, 2 (10)
  • [24] Unleashing the immune system: PD-1 and PD-Ls in the pre-treatment tumor microenvironment and correlation with response to PD-1/PD-L1 blockade
    Taube, Janis M.
    ONCOIMMUNOLOGY, 2014, 3 (11): : e963413 - 1
  • [25] Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial
    Demaria, Sandra
    Romano, Emanuela
    Brackstone, Muriel
    Formenti, Silvia C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [26] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    B Paiva
    A Azpilikueta
    N Puig
    E M Ocio
    R Sharma
    B O Oyajobi
    S Labiano
    L San-Segundo
    A Rodriguez
    I Aires-Mejia
    I Rodriguez
    F Escalante
    A G de Coca
    A Barez
    J F San Miguel
    I Melero
    Leukemia, 2015, 29 : 2110 - 2113
  • [27] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    Paiva, B.
    Azpilikueta, A.
    Puig, N.
    Ocio, E. M.
    Sharma, R.
    Oyajobi, B. O.
    Labiano, S.
    San-Segundo, L.
    Rodriguez, A.
    Aires-Mejia, I.
    Rodriguez, I.
    Escalante, F.
    de Coca, A. G.
    Barez, A.
    San Miguel, J. F.
    Melero, I.
    LEUKEMIA, 2015, 29 (10) : 2110 - 2113
  • [28] Features in genomics and tumor immune microenvironment in NSCLC treated with neoadjuvant PD-1 blockade.
    Wang, Shuhang
    Li, Ning
    Mao, Beibei
    Ying, Jianming
    Tao, Xiuli
    Tang, Wei
    Zhang, Lei
    Geng, Xiao
    Zhang, Fan
    Xue, Qi
    Wu, Lijia
    Zhang, Henghui
    Gao, Shugeng
    He, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy
    Wang, Xiaodong
    Yang, Xiaohui
    Zhang, Chang
    Wang, Yang
    Cheng, Tianyou
    Duan, Liqiang
    Tong, Zhou
    Tan, Shuguang
    Zhang, Hangjie
    Saw, Phei Er
    Gu, Yinmin
    Wang, Jinhua
    Zhang, Yibi
    Shang, Lina
    Liu, Yajuan
    Jiang, Siyuan
    Yan, Bingxue
    Li, Rong
    Yang, Yue
    Yu, Jie
    Chen, Yunzhao
    Gao, George Fu
    Ye, Qinong
    Gao, Shan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (12) : 6640 - 6650
  • [30] Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade
    Shuhang Wang
    Pei Yuan
    Beibei Mao
    Ning Li
    Jianming Ying
    Xiuli Tao
    Wei Tang
    Lei Zhang
    Xiao Geng
    Fan Zhang
    Qi Xue
    Lijia Wu
    Henghui Zhang
    Shugeng Gao
    Jie He
    npj Precision Oncology, 6
12345